Who Owns GRAIL Stock?
NASDAQ: GRALHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 86.22%
- Held by insiders
- 5.06%
- Institutional holders
- 552
- Institutions 86.2%
- Insiders 5.1%
- Public and other 8.7%
Who owns GRAIL stock?
Institutional investors own about 86.2% of GRAIL's shares, spread across 552 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 5.06% of GRAL.
The largest institutional holders are Farallon Capital Management LLC (9.26%), Baker Bros. Advisors, LP (8.96%) and Blackrock Inc. (8.52%). Together, the top 10 institutions control 54.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their GRAL positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GRAL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Farallon Capital Management LLC | 4.16M | 9.26% | +27.9% |
| Baker Bros. Advisors, LP | 4.03M | 8.96% | 0.0% |
| Blackrock Inc. | 3.83M | 8.52% | +7.1% |
| Primecap Management Company | 2.22M | 4.94% | +1.9% |
| Sessa Capital IM, L.P. | 2.04M | 4.53% | +18.5% |
| State Street Corporation | 2.02M | 4.48% | -15.5% |
| Vanguard Capital Management LLC | 1.85M | 4.10% | +12.4% |
| Deep Track Capital, Lp | 1.83M | 4.08% | +6.5% |
| Morgan Stanley | 1.24M | 2.75% | -15.5% |
| Geode Capital Management, LLC | 1.12M | 2.48% | +12.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GRAL
| Fund | Shares | % Held |
|---|---|---|
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 1.58M | 3.51% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.23M | 2.73% |
| iShares Trust-iShares Russell 2000 ETF | 1.07M | 2.38% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 979.35K | 2.18% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 452.48K | 1.01% |
| iShares Trust-iShares Russell 2000 Value ETF | 387.26K | 0.86% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 374.39K | 0.83% |
| iShares Trust-iShares Biotechnology ETF | 328.88K | 0.73% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 236.70K | 0.53% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 205.12K | 0.46% |
Frequently asked questions
Who is the largest shareholder of GRAIL?
Farallon Capital Management LLC is the largest institutional shareholder of GRAL, owning 9.26% of shares outstanding (4.16M shares) as of its latest 13F filing.
What percentage of GRAIL is owned by institutions?
Institutions own about 86.2% of GRAL shares and 90.8% of the public float.
How much of GRAIL do insiders own?
Insiders, such as officers and directors, own about 5.06% of GRAL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.